Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.

Jeffery Wei Heng KohCheng Han NgSen Hee Tay

Published in: Lupus (2020)

This meta-analysis substantiates IFNAR as a therapeutic target in SLE. Inhibition of type I IFNs predisposes to herpes zoster and other viral infections.

Keyphrases

systematic review
systemic lupus erythematosus
meta analyses
disease activity
sars cov
rheumatoid arthritis
cancer therapy
randomized controlled trial
drug delivery